High-dose chemotherapy with etoposide, cyclophosphamide and escalating dose of carboplatin followed by autologous bone marrow transplantation in cancer patients. A pilot study
- 1 January 1993
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (10) , 1398-1403
- https://doi.org/10.1016/0959-8049(93)90010-d
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Autologous bone marrow transplantation in solid tumorsCurrent Opinion in Oncology, 1992
- High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors. Early intervention is better toleratedCancer, 1992
- Long-term survivors after salvage high dose chemotherapy with bone marrow rescue in refractory germ cell cancerEuropean Journal of Cancer and Clinical Oncology, 1991
- Iproplatin and carboplatin induced toxicities: Overview of phase II clinical trial conducted by the EORTC early clinical trials cooperative group (ECTG)European Journal of Cancer and Clinical Oncology, 1988
- Clinical pharmacology of high-dose etoposide associated with cisplatin. Pharmacokinetic and metabolic studiesEuropean Journal of Cancer and Clinical Oncology, 1987
- Phase I clinical trial and pharmacokinetics of carboplatin (nsc 241240) by single monthly 30-minute infusionCancer, 1986
- Ovarian trials at the Royal MarsdenCancer Treatment Reviews, 1985
- High-dose VP-16-213 monotherapy for refractory germinal malignancies: a phase II study.Journal of Clinical Oncology, 1984
- Renal and Electrolyte Disturbances Associated with CisplatinAnnals of Internal Medicine, 1981
- High-dose cyclophosphamide therapy for malignant disease.Toxicity, tumor response, and the effects of stored autologous marrowCancer, 1972